Aspen Pharmacare: Number of Employees 2017-2023 | APNHY
Interactive chart of Aspen Pharmacare (APNHY) annual worldwide employee count from 2017 to 2023.
- Aspen Pharmacare total number of employees in 2023 was 9,161, a 0.07% decline from 2022.
- Aspen Pharmacare total number of employees in 2022 was 9,167, a 0.67% increase from 2021.
- Aspen Pharmacare total number of employees in 2021 was 9,106, a 7.72% decline from 2020.
- Aspen Pharmacare total number of employees in 2020 was 9,868, a 1.33% decline from 2019.
| Aspen Pharmacare Annual Employee Count | |
|---|---|
| 2023 | 9,161 |
| 2022 | 9,167 |
| 2021 | 9,106 |
| 2020 | 9,868 |
| 2019 | 10,001 |
| 2018 | 10,676 |
| 2017 | 10,204 |
| 2016 | 10,513 |
| 2015 | 10,331 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $5.574B | $2.296B |
| Aspen Pharmacare Holdings Limited provide specialty, branded and generic pharmaceuticals for acute and chronic conditions. It operates primarily in Sub-Saharan Africa, Latin America, South East Asia and Eastern Europe. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $15.673B | 5.66 |
| Dr Reddy's Laboratories (RDY) | India | $12.551B | 19.84 |
| BridgeBio Pharma (BBIO) | United States | $5.208B | 0.00 |
| Bausch Health Cos (BHC) | Canada | $2.868B | 2.18 |
| Amphastar Pharmaceuticals (AMPH) | United States | $2.042B | 14.20 |
| Supernus Pharmaceuticals (SUPN) | United States | $1.695B | 0.00 |
| Taysha Gene Therapies (TSHA) | United States | $0.481B | 0.00 |
| Generation Bio (GBIO) | United States | $0.211B | 0.00 |
| Personalis (PSNL) | United States | $0.078B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.072B | 0.00 |
| Acasti Pharma (ACST) | Canada | $0.028B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.024B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.004B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |